During the course of scientific research and the development process, researchers may often be confronted with unknown functional sequences. The recommended approach, prior to traditional experimental testing, is to explore their potential functionality and applicability by searching for analogous sequences and relevant patent data in established databases.

Merck has today made public the launch of the company's Phase 3 clinical trials, labeled as CORALreef, for MK-0616, a potential oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

Acquiring the sequence of a gene founded on its title is feasible and this article introduces one uncomplicated and swift technique that is consistently utilized.

PARP inhibitors had once brought about a "decade breakthrough" for ovarian cancer, and in search for new areas of business growth, AZ is primarily seeking the approval for the use of olaparib in metastatic prostate cancer.

Arvinas is currently conducting preclinical studies on protein degradation for neurodegenerative diseases.

This is the first and only RSV vaccine for pregnant women, marking an important milestone for public health.

With KRAS, a previously considered untouchable target, being cracked open, the KRAS G12C inhibitors of Amgen and Mirati are now on the market. The question is, how can we further optimize treatment outcomes for patients?

Adeno-associated virus (AAV) is reckoned as one of the most propitious vectors for gene research and therapy. It is recommended to use the Patsnap Bio sequence database to extract sequences analogous to definite AAV sequences and examine new AAV data from sources accessible to the public, thereby providing a catalyst for advanced AAV research.

We wait to see who will become the next drug king in the GLP-1 race.

Merck exercised its option to co-develop and commercialize mRNA-4157/V940 with Moderna for adjuvant treatment in high-risk melanoma patients.

Adeno-associated virus (AAV) is reckoned as one of the most propitious vectors for gene research and therapy. It is recommended to use the Patsnap Bio sequence database to extract sequences analogous to definite AAV sequences and examine new AAV data from sources accessible to the public, thereby providing a catalyst for advanced AAV research.

Synapse is a free drug intelligence database that streamlines research and enhances decision-making for pharmaceutical professionals. With extensive coverage of drugs, targets, and diseases, it provides valuable insights in emerging technology trends and competitive landscapes. Synapse supports partnership and investment decisions with detailed drug pipeline and investment history information.